Leigh Baldwin & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Buy
2,262
+87
+4% +$20.3K 0.31% 72
2026
Q1
$532K Hold
2,175
0.34% 72
2025
Q4
$450K Sell
2,175
-3,925
-64% -$776K 0.3% 87
2025
Q3
$1.13M Buy
6,100
+231
+4% +$39.6K 0.64% 37
2025
Q2
$896K Buy
5,869
+158
+3% +$24.3K 0.59% 42
2025
Q1
$947K Sell
5,711
-693
-11% -$108K 0.76% 35
2024
Q4
$926K Buy
+6,404
New +$992K 0.78% 36

Other funds holding JNJ

Leigh Baldwin & Co's JNJ Position: Q2 2026 in Review

Leigh Baldwin & Co increased its Johnson & Johnson (JNJ) stake by 4% in Q2 2026, buying an estimated $20.3K and bringing the position to 2,262 shares worth $574K. The position accounts for 0.31% of the portfolio, ranked #72.

Leigh Baldwin & Co first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q3 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Leigh Baldwin & Co held 2,262 shares of Johnson & Johnson worth $574K as of Q2 2026.
  • Leigh Baldwin & Co bought 87 Johnson & Johnson shares in Q2 2026, an estimated $20.3K.
  • Johnson & Johnson made up 0.31% of Leigh Baldwin & Co's portfolio in Q2 2026, its #72 holding.
  • Leigh Baldwin & Co first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's Johnson & Johnson position peaked at $1.13M in Q3 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.